Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

Food and Healthcare Press Releases Tuesday March 13, 2018 15:30
BANGALORE, India--13 Mar--PRNewswire/InfoQuest

A new study published in the international Nature Eye Journal demonstrates very high sensitivity for detecting Diabetic Retinopathy (DR) (95.8%) and Sight-threatening DR (99.1%) using Remidio's Fundus on Phone (FOP) device - an FDA 510k registered and CE marked smartphone-based retinal imaging device and Eyenuk's EyeArt Artificial Intelligence algorithm

Diabetes, a problem affecting more than 422 million globally, may lead to a sight-threatening condition called Diabetic Retinopathy (DR). 90% of the vision loss due to DR is preventable by early detection and timely treatment. Screening for DR has not been possible primarily due to two key challenges: (a) High Cost of Retinal Imaging Devices (b) Lack of access to specialist eye doctors, e.g., only 15,000 specialists are available to screen more than 70 million diabetics in India.

(Logo: https://mma.prnewswire.com/media/652990/Remidio_Logo.jpg )
(Photo: https://mma.prnewswire.com/media/652991/Remidio_Fundus_on_Phone.jpg )

Remidio Innovative Solutions based in Bangalore, India has disrupted the field of retinal imaging with their high quality, portable devices. The   Remidio Fundus on Phone (FOP) that works on smartphones, weighs 1/20th the size of conventional systems, costs just 1/5th the price, and can image without pupil dilation.

Until recently, DR could only be detected by ophthalmologists and trained graders. Artificial intelligence (AI), can now be employed to grade retinal images, especially those with sight-threatening DR.

In a study done at Madras Diabetes Research Foundation (MDRF), Chennai, and published by   Nature Eye , retinal photographs were taken on diabetics using the Remidio FOP, (previously validated to have a clinical sensitivity of 93% and specificity of 98%) and graded by ophthalmologists as well as by the AI algorithm EyeArt. This study showed that, the use of EyeArt automated AI along with Remidio Fundus on Phone (FOP) has very high sensitivity for detecting Diabetic   retinopathy (95.8%) and sight-threatening DR (99.1%). This is possibly the first study that has looked at the role and accuracy of automated Artificial Intelligence (AI) based DR detection in smartphone based retinal imaging.

Dr. Anand Sivaraman, CEO of Remidio Innovative Solutions Pvt. Ltd., said, "The simplicity of use of Remidio's smartphone based Fundus on Phone when combined with Artificial Intelligence like EyeArt, may now enable large scale public health screening for Diabetic Retinopathy globally."

For press queries contact:
Dr. Anand Sivaraman
+91-9845155475
anand@remidio.com
Source: Remidio Innovative Solutions

Latest Press Release

Medical Devices ASEAN 2018 supports the push to position Thailand as the medical hub of Asia

Medical Devices ASEAN 2018 ("MDA 2018") – the international exhibition and academic congress on medical devices, technologies, services and general healthcare – opens today and runs until Friday, 13 July 2018 at Hall 1-2, IMPACT Exhibition...

Berlinger Group Presents Arrangements for the Future Provision of Its World-renowned Anti-doping Products

- Distribution and further development of Berlinger anti-doping products to be entrusted to a foundation; Berlinger Board of Directors appoints new Group CEO The Swiss-based Berlinger Group (which comprises Berlinger & Co. AG and Berlinger Special...

Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India...

A Century After Umami#s Discovery, Its Benefits Continue to Expand

Umami, known as the savory taste, was discovered more than a century ago, yet recent research continues to document the benefits of umami. Currently underway is a year-long recognition of umami's 110th anniversary since its discovery in 1908. At one...

Merck Launches Online Platform Fertility.com

- Offering the latest scientific information to healthcare professionals in the advancing field of fertility - Supporting women, men and couples who are looking for information about fertility and/or undergoing fertility treatment (Photo:...

Related Topics